Hunter C - Search Results

1

A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.

Ondo W, Hunter C, Almaguer M, Jankovic J. Ondo W, et al. Among authors: hunter c. Mov Disord. 1999 Jul;14(4):664-8. doi: 10.1002/1531-8257(199907)14:4<664::aid-mds1017>3.0.co;2-5. Mov Disord. 1999. PMID: 10435505 Clinical Trial.

2

Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease.

Ondo W, Hunter C, Almaguer M, Gancher S, Jankovic J. Ondo W, et al. Among authors: hunter c. Clin Neuropharmacol. 1999 Jan-Feb;22(1):1-4. doi: 10.1097/00002826-199901000-00001. Clin Neuropharmacol. 1999. PMID: 10047926 Clinical Trial.

3

The pharmacokinetic and clinical effects of tolcapone on a single dose of sublingual apomorphine in Parkinson's disease.

Ondo WG, Hunter C, Vuong KD, Jankovic J. Ondo WG, et al. Among authors: hunter c. Parkinsonism Relat Disord. 2000 Oct 1;6(4):237-240. doi: 10.1016/s1353-8020(00)00019-5. Parkinsonism Relat Disord. 2000. PMID: 10900399

4

Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial.

Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Ondo W, et al. Among authors: hunter c. Mov Disord. 2000 Jul;15(4):678-82. doi: 10.1002/1531-8257(200007)15:4<678::aid-mds1012>3.0.co;2-0. Mov Disord. 2000. PMID: 10928578 Clinical Trial.

5

Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease.

Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, Lai D, Le WD. Xu PY, et al. Among authors: hunter c. Neurology. 2002 Mar 26;58(6):881-4. doi: 10.1212/wnl.58.6.881. Neurology. 2002. PMID: 11914402

6

A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease.

Jankovic J, Hunter C. Jankovic J, et al. Among authors: hunter c. Parkinsonism Relat Disord. 2002 Mar;8(4):271-6. doi: 10.1016/s1353-8020(01)00040-2. Parkinsonism Relat Disord. 2002. PMID: 12039422 Clinical Trial.

7

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.

Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ. Jankovic J, et al. Among authors: hunter c. Neurology. 2006 Dec 26;67(12):2233-5. doi: 10.1212/01.wnl.0000249308.66959.43. Neurology. 2006. PMID: 17190952 Clinical Trial.

8

Fatigue in levodopa-naive subjects with Parkinson disease.

Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S; Parkinson Study Group ELLDOPA Investigators. Schifitto G, et al. Neurology. 2008 Aug 12;71(7):481-5. doi: 10.1212/01.wnl.0000324862.29733.69. Neurology. 2008. PMID: 18695158 Free PMC article. Clinical Trial.

9

Clinical correlates of depressive symptoms in familial Parkinson's disease.

Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators. Pankratz N, et al. Mov Disord. 2008 Nov 15;23(15):2216-23. doi: 10.1002/mds.22285. Mov Disord. 2008. PMID: 18785635 Free PMC article.

10

Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, Myers RH; PSG-PROGENI and GenePD Investigators, Coordinators and Molecular Genetic Laboratories. Pankratz N, et al. Hum Genet. 2009 Jan;124(6):593-605. doi: 10.1007/s00439-008-0582-9. Epub 2008 Nov 6. Hum Genet. 2009. PMID: 18985386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,372 results

Search Page

Filters